Home » Topics » BioWorld Science

BioWorld Science
RSS

Beijing Innocare Medical Technology patents JAK inhibitors

July 13, 2022

Renovacor to advance AAV gene therapy program for arrhythmogenic cardiomyopathy

July 13, 2022

VesiVax Af3/9 vaccine protects against invasive pulmonary aspergillosis

July 13, 2022

LONP1 targeting sensitizes therapy-resistant tumor cells to sorafenib

July 13, 2022

Tenaya sets out rationale for targeting HDAC6 in heart failure

July 12, 2022

PARP/SIK2 inhibition shows potential for treating ovarian cancer and TNBC

July 12, 2022

iNtRON Biotechnology reports efficacy of CDL-200 against clinical isolates from CDI patients

July 12, 2022

MIF/CD74 axis identified as a critical determinant of TME composition in sarcoma

July 12, 2022

RS BioTherapeutics reports findings on RSBT-001 in mouse model of pulmonary inflammation

July 12, 2022

Novel murine models of diet-induced NASH developed

July 12, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...